XML 27 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock, At Cost
Retained (Deficit) Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balances (in shares) at Dec. 31, 2022   37,961,000        
Beginning balance at Dec. 31, 2022 $ 210.4 $ 0.4 $ 201.2 $ (19.5) $ 25.9 $ 2.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 3.0   3.0      
Issuance of restricted stock (in shares)   44,000        
Issuance of restricted stock 0.0   (0.7) 0.7    
Stock withheld for employee taxes (in shares)   (19,000)        
Stock withheld for employee taxes (0.5)   (0.2) (0.3)    
Proceeds from issuance of common stock (in shares)   29,000        
Proceeds from issuance of common stock 0.6   0.1 0.5    
Dividends $ (30.6)       (30.6)  
Purchase of treasury shares (in shares) 0          
Issuance of shares under employee stock purchase plan (in shares)   59,000        
Issuance of shares under employee stock purchase plan $ 1.4   1.4      
Change in cumulative translation adjustment 0.2         0.2
Net income 70.7       70.7  
Ending balances (in shares) at Dec. 31, 2023   38,074,000        
Ending balance at Dec. 31, 2023 255.2 $ 0.4 204.8 (18.6) 66.0 2.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 2.8   2.8      
Issuance of restricted stock (in shares)   73,000        
Issuance of restricted stock 0.0   (1.3) 1.3    
Stock withheld for employee taxes (in shares)   (39,000)        
Stock withheld for employee taxes (1.6)   (0.9) (0.7)    
Proceeds from issuance of common stock (in shares)   67,000        
Proceeds from issuance of common stock 1.8   0.6 1.2    
Dividends $ (38.4)       (38.4)  
Purchase of treasury shares (in shares) 0          
Issuance of shares under employee stock purchase plan (in shares)   55,000        
Issuance of shares under employee stock purchase plan $ 1.5   1.5      
Change in cumulative translation adjustment (1.2)         (1.2)
Net income $ 61.0       61.0  
Ending balances (in shares) at Dec. 31, 2024 38,230,328 38,230,000        
Ending balance at Dec. 31, 2024 $ 281.1 $ 0.4 207.5 (16.8) 88.6 1.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 7.4   7.4      
Issuance of restricted stock (in shares)   169,000        
Issuance of restricted stock 0.0   (3.0) 3.0    
Stock withheld for employee taxes (in shares)   (74,000)        
Stock withheld for employee taxes (2.3)   (1.0) (1.3)    
Proceeds from issuance of common stock (in shares)   130,000        
Proceeds from issuance of common stock 2.7   0.4 2.3    
Dividends $ (40.4)       (40.4)  
Purchase of treasury shares (in shares) (326,000) (326,000)        
Purchase of treasury shares $ (9.3)     (9.3)    
Issuance of shares under employee stock purchase plan (in shares)   70,000        
Issuance of shares under employee stock purchase plan 1.5   1.5      
Change in cumulative translation adjustment 0.4         0.4
Net income $ 72.1       72.1  
Ending balances (in shares) at Dec. 31, 2025 38,198,641 38,199,000        
Ending balance at Dec. 31, 2025 $ 313.2 $ 0.4 $ 212.8 $ (22.1) $ 120.3 $ 1.8